Hepatitis B immune globulin (Shenzhen Weiguang Biological)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B immune globulin (Shenzhen Weiguang Biological)
Drug Alias Name乙型肝炎人免疫球蛋白（深圳卫武光明）
ClassificationBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Weiguang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Weiguang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksWikipediaDrugBankKEGG